1. Home
  2. FLGC vs GLMD Comparison

FLGC vs GLMD Comparison

Compare FLGC & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flora Growth Corp.

FLGC

Flora Growth Corp.

HOLD

Current Price

$6.50

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

HOLD

Current Price

$0.78

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGC
GLMD
Founded
2019
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
6.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
FLGC
GLMD
Price
$6.50
$0.78
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
35.4K
82.8K
Earning Date
11-05-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$57,609,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.71
N/A
52 Week Low
$5.86
$0.73
52 Week High
$47.00
$3.50

Technical Indicators

Market Signals
Indicator
FLGC
GLMD
Relative Strength Index (RSI) 43.99 35.40
Support Level $6.17 $0.81
Resistance Level $8.07 $0.88
Average True Range (ATR) 0.61 0.06
MACD 0.07 0.00
Stochastic Oscillator 48.42 26.53

Price Performance

Historical Comparison
FLGC
GLMD

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Share on Social Networks: